DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1

告示番号

疾患名（ページ内リンク）

臨床試験数

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00151294 (ClinicalTrials.gov)	November 2004	6/9/2005	The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis	A Double-Blind, Placebo-Controlled Investigation Into the Safety and Efficacy of Escitalopram for Depression in Multiple Sclerosis	Depression;Multiple Sclerosis	Drug: escitalopram oxalate antidepressant	Weill Medical College of Cornell University	Forest Laboratories	Terminated	18 Years	N/A	Both	20	Phase 4	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

November 2004

6/9/2005

The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis

A Double-Blind, Placebo-Controlled Investigation Into the Safety and Efficacy of Escitalopram for Depression in Multiple Sclerosis

Depression;Multiple Sclerosis

Drug: escitalopram oxalate antidepressant

Weill Medical College of Cornell University

Forest Laboratories

Terminated

18 Years

N/A

Both

Phase 4

United States